Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Res ; 53(22): 5429-32, 1993 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-8221681

RESUMO

Interferon (IFN) has been shown to enhance the cytotoxic effects of 5-fluorouracil (5FUra) in colorectal cancer, and clinical trials with this combination resulted in higher response rate with respect to 5FUra alone. IFN is generally administered s.c. three times a week. This prolonged exposure could determine a block of tumor cells in the G0-G1 phase of the cell cycle, thus rendering tumor cells insensitive to 5FUra, an S-phase specific agent. In order to verify the presence of this block, 21 operable colorectal cancer patients were treated with IFN-alpha 2b at the dose of 3 megaunits every other day in the week before operation, while another 22 represented the control group. Samples of tumor tissue were taken at endoscopy and operation. [3H]Thymidine labeling index and flow cytometry were used to assess the S-phase fraction. In IFN treated patients, we found a significant statistical difference between the mean percentage of S-phase fractions evaluated either by labeling index (P = 0.00001) or by flow cytometry (P < 0.001). On the contrary, this difference was not present in the control group: labeling index, P = 0.06; flow cytometry, P = 0.08. Furthermore a significant increase in the G0-G1 phase of the cell cycle was found after IFN administration (P < 0.001) but not in the control group. Our results suggest that IFN reduces the S-phase fraction in colorectal cancer tumors. This action should be considered in the design of the 5FUra/IFN combination because it could decrease 5FUra activity, leading to a loss or a decrease in the advantage of 5FUra modulation by IFN.


Assuntos
Neoplasias Colorretais/terapia , Fluoruracila/farmacologia , Interferon-alfa/farmacologia , Adulto , Idoso , Ciclo Celular/efeitos dos fármacos , Neoplasias Colorretais/patologia , Interações Medicamentosas , Citometria de Fluxo , Humanos , Interferon alfa-2 , Pessoa de Meia-Idade , Proteínas Recombinantes , Fase S/efeitos dos fármacos
2.
Quad Sclavo Diagn ; 24(1-4): 21-7, 1988.
Artigo em Italiano | MEDLINE | ID: mdl-3268914

RESUMO

We analysed, in the period 1984-1986, the serum of 1733 pregnant women. The relation between the positivities and some probable factors of risk, alimentary habits and touch with tame animals has had valued by statistical method. The analysis shows no increase of risk in the group used to eat underdone meats compared with the group in touch tame animals.


Assuntos
Complicações Infecciosas na Gravidez/imunologia , Toxoplasmose/imunologia , Adolescente , Adulto , Animais , Animais Domésticos , Feminino , Contaminação de Alimentos , Temperatura Alta , Humanos , Carne , Gravidez , Complicações Infecciosas na Gravidez/sangue , Complicações Infecciosas na Gravidez/etiologia , Fatores de Risco , Toxoplasma , Toxoplasmose/sangue , Toxoplasmose/etiologia
3.
Quad Sclavo Diagn ; 24(1-4): 81-8, 1988.
Artigo em Italiano | MEDLINE | ID: mdl-3268922

RESUMO

The concentrations of the IgG and IgM fractions have been determined on thirty whole sera and after treatment with protein A, or after chromatographic separation. The analysis of the differences has been effected with Student's t test. No statistically significant differences have been noted between the two methods of separation as far as IgM fraction is concerned, but, on the contrary, significant differences are present for the separation of IgG fraction.


Assuntos
Imunoglobulina G/isolamento & purificação , Imunoglobulina M/isolamento & purificação , Testes Sorológicos/métodos , Estudos de Avaliação como Assunto , Feminino , Humanos , Gravidez , Testes Sorológicos/estatística & dados numéricos
4.
Quad Sclavo Diagn ; 22(3): 283-90, 1986 Sep.
Artigo em Italiano | MEDLINE | ID: mdl-3615801

RESUMO

The object of this study is an evaluation of the epidemic situation concerning the rubella in the pregnant population of age included between 18 and 40 years of the U.S.L. 3 of Pesaro, in the period 1981-1985. The percentage of seropositivity in an average is around 93.8%; nevertheless such a percentage of seronegativity persists as to justify an intervention of prophylaxis by means of vaccination above all in the age from 18 to 25 years, that represents the 43.8% of the examined sample. It must be pointed out the evolution of the immunity situation from the 36 to the 40 years.


Assuntos
Complicações Infecciosas na Gravidez/imunologia , Rubéola (Sarampo Alemão)/epidemiologia , Adolescente , Adulto , Surtos de Doenças , Métodos Epidemiológicos , Feminino , Humanos , Sistema Imunitário , Itália , Gravidez , Rubéola (Sarampo Alemão)/imunologia , Vacina contra Rubéola
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...